Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisbet Brandi

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Danish Medical Bulletin|February 24, 2009
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysisLisbet Brandi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic menLisbet Brandi, Martin Egfjord, Klaus Olgaard
BMC Nephrology|September 26, 2009
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidolDitte Hansen, Lisbet Brandi, Knud Rasmussen
Nephron. Clinical Practice|February 22, 2005
Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assaysLisbet Brandi, Martin Egfjord, Klaus Olgaard
Ugeskrift for Laeger|December 17, 2009
[Vitamin D, cardiovascular disease and mortality in patients with kidney disease]Ditte Hansen, Lisbet Brandi, Knud Rasmussen
Kidney International|November 27, 2014
In memoriam: Claus Brun, MD, Dr Med, 1914-2014Bo Feldt-Rasmussen, Lisbet Brandi, Klaus Olgaard
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 23, 2014
Claus Brun (1914-2014)Bo Feldt-Rasmussen, Lisbet Brandi, Klaus Olgaard
Clinical Journal of the American Society of Nephrology : CJASN|August 23, 2018
The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical TrialIain Bressendorff, Ditte Hansen, Morten Schou, et al.
BMC Nephrology|July 13, 2020
Pulmonary artery pressure as a method for assessing hydration status in an anuric hemodialysis patient - a case reportAnne Rudbeck Juhl, Jesper Juul Larsen, Kasper Rossing, et al.
BMJ Open|June 25, 2017
The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationaleIain Bressendorff, Ditte Hansen, Morten Schou, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Danish Medical Bulletin|February 24, 2009
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysisLisbet Brandi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic menLisbet Brandi, Martin Egfjord, Klaus Olgaard
BMC Nephrology|September 26, 2009
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidolDitte Hansen, Lisbet Brandi, Knud Rasmussen
Nephron. Clinical Practice|February 22, 2005
Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assaysLisbet Brandi, Martin Egfjord, Klaus Olgaard
Ugeskrift for Laeger|December 17, 2009
[Vitamin D, cardiovascular disease and mortality in patients with kidney disease]Ditte Hansen, Lisbet Brandi, Knud Rasmussen
Kidney International|November 27, 2014
In memoriam: Claus Brun, MD, Dr Med, 1914-2014Bo Feldt-Rasmussen, Lisbet Brandi, Klaus Olgaard
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 23, 2014
Claus Brun (1914-2014)Bo Feldt-Rasmussen, Lisbet Brandi, Klaus Olgaard
Clinical Journal of the American Society of Nephrology : CJASN|August 23, 2018
The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical TrialIain Bressendorff, Ditte Hansen, Morten Schou, et al.
BMC Nephrology|July 13, 2020
Pulmonary artery pressure as a method for assessing hydration status in an anuric hemodialysis patient - a case reportAnne Rudbeck Juhl, Jesper Juul Larsen, Kasper Rossing, et al.
BMJ Open|June 25, 2017
The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationaleIain Bressendorff, Ditte Hansen, Morten Schou, et al.
Pageof 4